These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26813562)

  • 1. Autoantibodies against Linear Epitopes of Myeloperoxidase in Anti-Glomerular Basement Membrane Disease.
    Li JN; Cui Z; Wang J; Hu SY; Jia XY; Guan Z; Chen M; Xie C; Zhao MH
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):568-75. PubMed ID: 26813562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against linear epitopes on the Goodpasture autoantigen and kidney injury.
    Jia XY; Cui Z; Yang R; Hu SY; Zhao MH
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):926-33. PubMed ID: 22461538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An experience of treatment of double positive myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and anti-glomerular basement membrane antibodies in Goodpasture's syndrome onset of crescentic glomerulonephritis].
    Takeda T; Takeda T; Naiki Y; Yonekawa S; Sakaguchi M; Iwamoto I; Tanaka H; Hasegawa H; Imada A; Kanamaru A; Hiruma S; Maekura S; Hashimoto S; Yamazumi T
    Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):591-6. PubMed ID: 9893458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against linear epitopes on Goodpasture autoantigen in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Jia XY; Yu JT; Hu SY; Li JN; Wang M; Wang C; Chen M; Cui Z; Zhao MH
    Clin Rheumatol; 2017 Sep; 36(9):2087-2094. PubMed ID: 28550388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
    Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
    Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.
    Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH
    Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deglycosylation of myeloperoxidase uncovers its novel antigenicity.
    Yu JT; Li JN; Wang J; Jia XY; Cui Z; Zhao MH
    Kidney Int; 2017 Jun; 91(6):1410-1419. PubMed ID: 28187981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes.
    McCall AS; Bhave G; Pedchenko V; Hess J; Free M; Little DJ; Baker TP; Pendergraft WF; Falk RJ; Olson SW; Hudson BG
    J Am Soc Nephrol; 2018 Nov; 29(11):2619-2625. PubMed ID: 30279272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical consequence and significance of anti-neutrophil cytoplasmic antibody positivity in anti-glomerular basement membrane disease].
    File I; Pucsok K; Trinn C; Ujhelyi L; Balla J; Mátyus J
    Orv Hetil; 2013 Oct; 154(43):1696-701. PubMed ID: 24140508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of epitope spreading of antiglomerular basement membrane antibodies and kidney injury.
    Chen JL; Hu SY; Jia XY; Zhao J; Yang R; Cui Z; Zhao MH
    Clin J Am Soc Nephrol; 2013 Jan; 8(1):51-8. PubMed ID: 23085731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis].
    Yamazaki C; Arai S; Tamura Y; Suzuki Y; Nakajima H; Kojima K; Uchida S
    Nihon Jinzo Gakkai Shi; 2009; 51(4):490-5. PubMed ID: 19601559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
    Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
    Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcomes of anti-glomerular basement membrane disease in older patients.
    Cui Z; Zhao J; Jia XY; Zhu SN; Zhao MH
    Am J Kidney Dis; 2011 Apr; 57(4):575-82. PubMed ID: 21168945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies.
    Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
    J Am Soc Nephrol; 2007 Apr; 18(4):1338-43. PubMed ID: 17329569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating autoantibodies as serological markers in the differential diagnosis of pulmonary renal syndrome.
    Saxena R; Bygren P; Arvastson B; Wieslander J
    J Intern Med; 1995 Aug; 238(2):143-52. PubMed ID: 7629482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane antibody (anti-GBM Ab)].
    Kobayashi M; Saito M; Minoshima S; Arimura Y; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):207-11. PubMed ID: 7731110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating autoantibodies in patients with extracapillary glomerulonephritis.
    Saxena R; Bygren P; Rasmussen N; Wieslander J
    Nephrol Dial Transplant; 1991; 6(6):389-97. PubMed ID: 1652114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The heterogeneity of anti-GBM autoantibodies in sera from patients with anti-GBM disease and its clinical correlation].
    Liu C; Qu Z; Yang R; Zhao J; Jia XY; Zheng X; Liu ZS; Cui Z; Zhao MH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 41(6):625-9. PubMed ID: 20019770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease.
    Ohlsson S; Herlitz H; Lundberg S; Selga D; Mölne J; Wieslander J; Segelmark M
    Am J Kidney Dis; 2014 Feb; 63(2):289-93. PubMed ID: 24189476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.